#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Malignant central nervous system neoplasm Cutaneous lupus erythematosus Microscopic polyangiitis Hepatitis B Marfan's syndrome Retinoblastoma Leukocyte adhesion deficiency type I Andersen-Tawil syndrome Ventricular tachycardia Type IIa hyperlipidaemia Chemical burn Hypochromic anaemia Thyroid cancer metastatic Congenital aplastic anaemia Non-small cell lung cancer metastatic More trials…

    Learn about Rare Diseases

    Myelodysplastic syndrome with excess blasts – Basic Information MELAS syndrome – Treatment Familial haemophagocytic lymphohistiocytosis – Diagnostics Hereditary angioedema with C1 esterase inhibitor deficiency – Basic Information Mantle cell lymphoma stage IV – Treatment Hereditary angioedema – Diagnostics Loeys-Dietz syndrome – Treatment Thrombotic thrombocytopenic purpura – Basic Information Myelodysplastic syndrome – Life with Disease Richter’s syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Enasidenib Mesilate Cft1946 Ganciclovir Sodium Lamivudine Ieramilimab Levamlodipine Succinate Roginolisib Ramipril IHMA-2121908-1 Lumateperone Altizide Budesonide Ticagrelor Gskvx000000008866 COLESEVELAM HYDROCHLORIDE Hydroxypropylbetadex M1P Dipotassium Salt Db-1303 Clopidogrel Hydrogen Sulfate Enlicitide Chloride More therapies…

    Learn about Your Condition

    Crigler-Najjar syndrome Post procedural complication Langerhans cell sarcoma Penile squamous cell carcinoma Intestinal infarction Colorectal cancer stage III Tinnitus Aortic valve stenosis Mucosal inflammation Angiosarcoma Cardiogenic shock Acne Endocrine ophthalmopathy Leukaemia Chronic lymphocytic leukaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Breast cancer

  • Study on Indocyanine Green in Axillary Lymph Nodes for Patients with Breast Cancer and Metastatic Lymph Nodes

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Indocyanine Green
    Italy

  • Study Comparing Trastuzumab Deruxtecan with a Drug Combination for Patients with HER2+ Early Breast Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • HER2 positive breast cancer
    • Breast cancer
    • Breast cancer female
    Investigated Drugs:
    • Trastuzumab Deruxtecan
    Germany

  • Study of elacestrant and ribociclib compared to standard treatment for patients with high-risk ER+/HER2- early breast cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer male
    • Human epidermal growth factor receptor negative
    • Breast cancer
    Investigated Drugs:
    • Elacestrant
    • Ribociclib
    Austria Germany Spain

  • Study Comparing Imlunestrant with Standard Endocrine Therapy for Patients with Early ER+, HER2- Breast Cancer at Increased Risk of Recurrence

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Anastrozole
    • Exemestane
    • Letrozole
    Austria Belgium Czechia Finland France Germany +10

  • Phase II Study of [68Ga]Ga-FAP-2286 PET/CT for Staging and Restaging Newly Diagnosed Primary Breast Cancer Patients

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Breast cancer
    Denmark

  • Evaluation of zongertinib, fulvestrant and goserelin acetate in patients with HR‑positive HER2‑negative advanced breast cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Hormone receptor positive HER2 negative breast cancer
    • Breast cancer
    Investigated Drugs:
    • Goserelin Acetate
    • Fulvestrant
    • Zongertinib
    Germany Italy Spain
Previous Page
1 … 10 11 12 13 14 … 28
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!